Benzbromarone as a Novel Candidate for Preventing Alzheimer's Disease: Evidence From Real-World Data Screening and in Vitro Validation. [PDF]
Clin Transl SciSakagami S +11 more
europepmc +1 more source
Effect of dotinurad versus febuxostat on the one-year eGFR slope in CKD patients with hyperuricemia: a retrospective cohort study. [PDF]
BMC NephrolUematsu H, Toida T, Tanaka Y, Joki N.
europepmc +1 more source
Structure-activity relationship studies of febuxostat derivatives identify potent anti-lung cancer agents that induce DNA damage and autophagy. [PDF]
Sci RepHou X, Zhang X, Guo J, Guo Y, Yang J.
europepmc +1 more source
When Joint Aspiration Fails: Point-of-Care Ultrasound for Diagnosing Chronic Gout in Prolonged Monoarthritis. [PDF]
J Gen Fam MedYamada T.
europepmc +1 more source
Febuxostat effectively reduces uric acid but has a limited renoprotective effect on renal transplant recipients with hyperuricemia: a meta-analysis. [PDF]
Front PharmacolChao S, Zhu K, Jia L, Liu Y.
europepmc +1 more source
Cinnamaldehyde Attenuates Hyperuricemia-Associated Renal Injury by Modulating Urate Transporters and AIF1- and CMPK2/NLRP3-Related Inflammatory Signaling. [PDF]
Pharmaceuticals (Basel)Sun Y +5 more
europepmc +1 more source
Febuxostat Enhances the Antitumor Efficacy of 2-Fluoroadenine and 5'-Methylthioadenosine in MTAP-Deleted Cancer. [PDF]
Cancer Res CommunTang B +5 more
europepmc +1 more source
Successful Extended Allopurinol Desensitization in an Elderly Patient With Chronic Kidney Disease and Febuxostat Intolerance. [PDF]
CureusRamesh R +2 more
europepmc +1 more source
Serum Uric Acid in Chronic Kidney Disease as a Marker of Risk or a Modifiable Driver of Progression: A Systematic Review. [PDF]
CureusCook DE +7 more
europepmc +1 more source
Allopurinol and Febuxostat Hypersensitivity in a Patient with Young Onset Gout: A Case Report. [PDF]
Acta Med PhilippYano MAO, Magbitang-Santiago AT.
europepmc +1 more source